Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in Vivo-Reference-Cited by-同舟云学术

Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in Vivo

Published:1996-06-28 Issue:5270 Volume:272 Page:1947-1950
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Tough David F.¹,Borrow Persephone²,Sprent Jonathan¹

Affiliation:

1. D. F. Tough and J. Sprent, Department of Immunology, IMM4, Scripps Research Institute, 10666 North Torrey Pines Road, La Jolla, California 92037, USA.

2. P. Borrow, Department of Neuropharmacology, IMM6, Scripps Research Institute, 10666 North Torrey Pines Road, La Jolla, California 92037, USA.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference32 articles.

1. THE STABLE AND PERMANENT EXPANSION OF FUNCTIONAL LYMPHOCYTES-T IN ATHYMIC NUDE RATS AFTER A SINGLE INJECTION OF MATURE-T CELLS;BELL E.B.;JOURNAL OF IMMUNOLOGY,1987

2. IS T-CELL MEMORY MAINTAINED BY CROSS-REACTIVE STIMULATION;BEVERLEY PCL;IMMUNOLOGY TODAY,1990

3. ON THE CELLULAR BASIS OF IMMUNOLOGICAL T-CELL MEMORY;BRUNO L;IMMUNITY,1995

4. INTERFERON-ALPHA-BETA ENHANCES THE EXPRESSION OF LY-6 ANTIGENS ON T-CELLS INVIVO AND INVITRO;DUMONT F.J.;EUROPEAN JOURNAL OF IMMUNOLOGY,1986

5. GENOMIC AND BIOLOGICAL VARIATION AMONG COMMONLY USED LYMPHOCYTIC CHORIOMENINGITIS VIRUS-STRAINS;DUTKO F.J.;JOURNAL OF GENERAL VIROLOGY,1983

Cited by 968 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study of Ridostin Pro and Poly(I:C) as adjuvants that enhance the immunogenicity of an antitumor vaccine;Siberian journal of oncology;2024-07-04

2. Cellular pathways and molecular events that shape autoantibody production in COVID-19;Journal of Autoimmunity;2024-07

3. Steady-state, therapeutic, and helminth-induced IL-4 compromise protective CD8 T cell bystander activation;2024-06-12

4. Understanding autoimmune response after SARS-CoV-2 infection and the pathogenesis/mechanisms of long COVID;Medical Review;2024-05-27

5. Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies;Frontiers in Immunology;2024-05-16